Spondylarthropathies clinical trials

The registry lists 68 studies for Spondylarthropathies across more than 10 countries. 10 are recruiting or about to start. 28 of them are mainly about Spondylarthropathies (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its 4 narrower conditions too, such as Arthritis, Psoriatic: 1,171 studies, 242 open.

Get an email when these change. Save the Spondylarthropathies studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 43
Status unknown: 10
Recruiting: 6
Not yet recruiting: 3
Active, not recruiting: 2
Terminated: 2

Phase

Phase 3: 12
Phase 4: 9
Phase 2: 7
Early Phase 1: 1

Where

United States: 14
France: 12
Canada: 11
Germany: 10
Spain: 10
Netherlands: 8

Who runs them

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (3) · Region Skane (3) · UCB BIOSCIENCES GmbH (3) · University Hospital, Grenoble (2) · University of Southern Denmark (2) · Universidad de Extremadura (2) · Sohag University (2) · Charite University, Berlin, Germany (2)

What is being tested here

Drugs under test in Spondylarthropathies studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Shingrix	1	0	1
Certolizumab Pegol	0	3	3
Etanercept	0	0	3
Golimumab	0	2	3
Methotrexate	0	1	2
Infliximab	0	1	2
Apremilast	0	1	1
Ixekizumab	0	1	1
Celecoxib	0	0	1
Adalimumab	0	1	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Sep 2027Identification of Serum Level of Glutathione Peroxidase 4 · Assiut University
Oct 2027Phase 2 Trial of FT2109 for the Treatment of Psoriatic Arthritis · Forward Therapeutics

Who these studies take

Of the 6 Spondylarthropathies studies recruiting now, 2 (33%) set no upper age limit and 3 (50%) stop at 75 or younger. 1 (17%) take children under 18. 0 (0%) are for women only and 1 (17%) for men only; 1 (17%) take healthy volunteers.

Recruiting studies that take each age, of 6
Age	Women	Men
10	1 (17%)	1 (17%)
18	4 (67%)	5 (83%)
30	4 (67%)	5 (83%)
40	4 (67%)	5 (83%)
50	4 (67%)	5 (83%)
65	3 (50%)	4 (67%)
75	3 (50%)	3 (50%)
85	3 (50%)	3 (50%)

Across all 68 studies, recruiting or not: 37% stop at 75 or younger and 26% at 65; 10% take children; 0% are for women only and 1% for men only; 13% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Identification of Serum Level of Glutathione Peroxidase 4Nov 5, 2026NCT06554392

Studies

Recruiting first, then most recently updated. Showing 50 of 68. Browse all 68 → or search them.